help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pyke, C.
Right arrow Articles by Dano, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pyke, C.
Right arrow Articles by Dano, K.

American Journal of Pathology, Vol 138, 1059-1067, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

C Pyke, P Kristensen, E Ralfkiaer, J Grondahl-Hansen, J Eriksen, F Blasi and K Dano
Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

In this study in situ hybridization methods were used to examine biopsy samples from 13 adenocarcinomas of the colon for the presence of mRNA for the urokinase-type plasminogen activator (u-PA) and its specific cell-surface receptor (u-PAR). In all cases, u-PA mRNA was present in fibroblastlike cells in the stroma adjacent to the invasive tumor nodules. Urokinase-type plasminogen activator mRNA was not detected in the malignant cells. All specimens also contained u-PAR mRNA in cells located at the tumoral-stromal interface of invasive foci, but in contrast at least some of these cells were in all but one case identified as being of malignant origin. Stromal cells, probably tumor- infiltrating macrophages and neutrophils, also were positive in these areas. These results support the view that components of the plasminogen activation system may act to influence proteolytic events occurring at the interface between stroma and malignant cells in adenocarcinomas of the colon in humans.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. M. K. Pulukuri and J. S. Rao
Small Interfering RNA Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis
Cancer Res., July 15, 2007; 67(14): 6637 - 6646.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. K. Pulukuri, N. Estes, J. Patel, and J. S. Rao
Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer
Cancer Res., February 1, 2007; 67(3): 930 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
M. Illemann, N. Bird, A. Majeed, M. Sehested, O. D. Laerum, L. R. Lund, K. Dano, and B. S. Nielsen
MMP-9 Is Differentially Expressed in Primary Human Colorectal Adenocarcinomas and Their Metastases
Mol. Cancer Res., May 1, 2006; 4(5): 293 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
B. Rono, J. Romer, S. Liu, T. H. Bugge, S. H. Leppla, and P. E.G. Kristjansen
Antitumor efficacy of a urokinase activation-dependent anthrax toxin
Mol. Cancer Ther., January 1, 2006; 5(1): 89 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S. J. Shin, K. O. Kim, M. K. Kim, K. H. Lee, M. S. Hyun, K. J. Kim, J. H. Choi, and H. S. Song
Expression of E-Cadherin and uPA and their Association with the Prognosis of Pancreatic Cancer
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 342 - 348.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. Cavallo-Medved, J. Mai, J. Dosescu, M. Sameni, and B. F. Sloane
Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells
J. Cell Sci., April 1, 2005; 118(7): 1493 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
R. Pai, A. S. Tarnawski, and T. Tran
Deoxycholic Acid Activates {beta}-Catenin Signaling Pathway and Increases Colon Cell Cancer Growth and Invasiveness
Mol. Biol. Cell, May 1, 2004; 15(5): 2156 - 2163.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Bruse, D. Radu, and A. Bergqvist
In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue
Mol. Hum. Reprod., March 1, 2004; 10(3): 159 - 166.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. R. Harvey, T. C. Hurd, G. Markus, M. I. Martinick, R. M. Penetrante, D. Tan, P. Venkataraman, N. DeSouza, S. N. J. Sait, D. L. Driscoll, et al.
Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer
Clin. Cancer Res., October 15, 2003; 9(13): 4935 - 4943.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. S. Palumbo, K. E. Talmage, H. Liu, C. M. La Jeunesse, D. P. Witte, and J. L. Degen
Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency
Blood, October 15, 2003; 102(8): 2819 - 2827.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. PAI, T. NAKAMURA, W. S. MOON, and A. S. TARNAWSKI
Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors
FASEB J, September 1, 2003; 17(12): 1640 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, et al.
Regulation of Colon Carcinoma Cell Invasion by Hypoxia-Inducible Factor 1
Cancer Res., March 1, 2003; 63(5): 1138 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. S. Palumbo, J. M. Potter, L. S. Kaplan, K. Talmage, D. G. Jackson, and J. L. Degen
Spontaneous Hematogenous and Lymphatic Metastasis, but not Primary Tumor Growth or Angiogenesis, Is Diminished in Fibrinogen-deficient Mice
Cancer Res., December 1, 2002; 62(23): 6966 - 6972.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. M. Heiss, E. H. Simon, B. C.M. Beyer, K. U. Gruetzner, A. Tarabichi, R. Babic, F. W. Schildberg, and H. Allgayer
Minimal Residual Disease in Gastric Cancer: Evidence of an Independent Prognostic Relevance of Urokinase Receptor Expression by Disseminated Tumor Cells in the Bone Marrow
J. Clin. Oncol., April 15, 2002; 20(8): 2005 - 2016.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. S. Nielsen, F. Rank, J. M. Lopez, M. Balbin, F. Vizoso, L. R. Lund, K. Dano, and C. Lopez-Otin
Collagenase-3 Expression in Breast Myofibroblasts as a Molecular Marker of Transition of Ductal Carcinoma in Situ Lesions to Invasive Ductal Carcinomas
Cancer Res., October 1, 2001; 61(19): 7091 - 7100.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Helenius, O. R. Saramaki, M. J. Linja, T. L. J. Tammela, and T. Visakorpi
Amplification of Urokinase Gene in Prostate Cancer
Cancer Res., July 1, 2001; 61(14): 5340 - 5344.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. B. Siconolfi and N. W. Seeds
Induction of the Plasminogen Activator System Accompanies Peripheral Nerve Regeneration after Sciatic Nerve Crush
J. Neurosci., June 15, 2001; 21(12): 4336 - 4347.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
H. Solberg, M. Ploug, G. Høyer–Hansen, B. S. Nielsen, and L. R. Lund
The Murine Receptor for Urokinase-Type Plasminogen Activator Is Primarily Expressed in Tissues Actively Undergoing Remodeling
J. Histochem. Cytochem., February 1, 2001; 49(2): 237 - 246.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
L. Adam, A. Mazumdar, T. Sharma, T. R. Jones, and R. Kumar
A Three-Dimensional and Temporo-Spatial Model to Study Invasiveness of Cancer Cells by Heregulin and Prostaglandin E2
Cancer Res., January 1, 2001; 61(1): 81 - 87.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. Mazumdar, L. Adam, D. Boyd, and R. Kumar
Heregulin Regulation of Urokinase Plasminogen Activator and its Receptor: Human Breast Epithelial Cell Invasion
Cancer Res., January 1, 2001; 61(1): 400 - 405.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. L. Frandsen, C. Holst-Hansen, B. S. Nielsen, I. J. Christensen, J. R. Nyengaard, P. Carmeliet, and N. Brünner
Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model
Cancer Res., January 1, 2001; 61(2): 532 - 537.
[Abstract] [Full Text]

Home page
 Mol. Pathol.Home page
E A Baker, F G Bergin, and D J Leaper
Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression
Mol. Pathol., December 1, 2000; 53(6): 307 - 312.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
H. Kataoka, R. Hamasuna, H. Itoh, N. Kitamura, and M. Koono
Activation of Hepatocyte Growth Factor/Scatter Factor in Colorectal Carcinoma
Cancer Res., November 1, 2000; 60(21): 6148 - 6159.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
M. N. Holten-Andersen, R. W. Stephens, H. J. Nielsen, G. Murphy, I. J. Christensen, W. Stetler-Stevenson, and N. Brunner
High Preoperative Plasma Tissue Inhibitor of Metalloproteinase-1 Levels Are Associated with Short Survival of Patients with Colorectal Cancer
Clin. Cancer Res., November 1, 2000; 6(11): 4292 - 4299.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
K. Koli and J. Keski-Oja
1{{alpha}},25-Dihydroxyvitamin D3 and Its Analogues Down-Regulate Cell Invasion-associated Proteases in Cultured Malignant Cells
Cell Growth Differ., April 1, 2000; 11(4): 221 - 229.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
H. Shiomi, Y. Eguchi, T. Tani, M. Kodama, and T. Hattori
Cellular Distribution and Clinical Value of Urokinase-Type Plasminogen Activator, Its Receptor, and Plasminogen Activator Inhibitor-2 in Esophageal Squamous Cell Carcinoma
Am. J. Pathol., February 1, 2000; 156(2): 567 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. R. Harvey, S. N. J. Sait, Y. Xu, J. L. Bailey, R. M. Penetrante, and G. Markus
Demonstration of Urokinase Expression in Cancer Cells of Colon Adenocarcinomas by Immunohistochemistry and in Situ Hybridization
Am. J. Pathol., October 1, 1999; 155(4): 1115 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. W. Stephens, H. J. Nielsen, I. J. Christensen, O. Thorlacius-Ussing, S. Sorensen, K. Dano, and N. Brunner
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis
J Natl Cancer Inst, May 19, 1999; 91(10): 869 - 874.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Allgayer, H. Wang, Y. Wang, M. M. Heiss, R. Bauer, O. Nyormoi, and D. Boyd
Transactivation of the Urokinase-type Plasminogen Activator Receptor Gene through a Novel Promoter Motif Bound with an Activator Protein-2alpha -related Factor
J. Biol. Chem., February 19, 1999; 274(8): 4702 - 4714.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al.
Urokinase type plasminogen activator receptor expression in colorectal neoplasms
Gut, December 1, 1998; 43(6): 798 - 805.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
P R Gibson, I Birchall, O Rosella, V Albert, C F Finch, D H Barkla, and G P Young
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover
Gut, November 1, 1998; 43(5): 656 - 663.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
U. Cavallaro, Z. Wu, A. D. Palo, R. Montesano, M. S. Pepper, J. A. M. maier, and M. R. Soria
FGF-2 stimulates migration of Kaposi's sarcoma-like vascular cells by HGF-dependent relocalization of the urokinase receptor
FASEB J, August 1, 1998; 12(11): 1027 - 1034.
[Abstract] [Full Text]

Home page
 BloodHome page
T. H. Bugge, K. W. Kombrinck, Q. Xiao, K. Holmback, C. C. Daugherty, D. P. Witte, and J. L. Degen
Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice
Blood, December 1, 1997; 90(11): 4522 - 4531.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
T. Plesner, N. Behrendt, and M. Ploug
Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase-Type Plasminogen Activator Receptor, uPAR
Stem Cells, November 1, 1997; 15(6): 398 - 408.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
R. W. Stephens, A. N. Pedersen, H. J. Nielsen, M. J. A. G. Hamers, G. Hoyer-Hansen, E. Ronne, E. Dybkjær, K. Dano, and N. Brunner
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients
Clin. Chem., October 1, 1997; 43(10): 1868 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
R. Ciccocioppo, M. G. Capri, and S. Alberti
Detection of the Receptor for the Human Urokinase-type Plasminogen Activator Using Fluoresceinated uPA
J. Histochem. Cytochem., September 1, 1997; 45(9): 1307 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
W. Yu, J. Kim, and L. Ossowski
Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
J. Cell Biol., May 5, 1997; 137(3): 767 - 777.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. P. Irigoyen, D. Besser, and Y. Nagamine
Cytoskeleton Reorganization Induces the Urokinase-type Plasminogen Activator Gene via the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway
J. Biol. Chem., January 17, 1997; 272(3): 1904 - 1909.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. A. Reidy, C. Irvin, and V. Lindner
Migration of Arterial Wall Cells : Expression of Plasminogen Activators and Inhibitors in Injured Rat Arteries
Circ. Res., March 1, 1996; 78(3): 405 - 414.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. J. Mandriota, G. Seghezzi, J.-D. Vassalli, N. Ferrara, S. Wasi, R. Mazzieri, P. Mignatti, and M. S. Pepper
Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells
J. Biol. Chem., April 28, 1995; 270(17): 9709 - 9716.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Y. Strongin, I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant, and G. I. Goldberg
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
J. Biol. Chem., March 10, 1995; 270(10): 5331 - 5338.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction
J. Biol. Chem., January 13, 1995; 270(2): 603 - 611.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Liu, T. H. Bugge, and S. H. Leppla
Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin
J. Biol. Chem., May 18, 2001; 276(21): 17976 - 17984.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.